Ligand validation:8PRX

KH0: ~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{S})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate

KH0 is a Ligand Of Interest in 8PRX designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8PRX_KH0_D_602	49%	76%	0.172	0.919	0.32	0.62	-	-	0	0	100%	1
8PRX_KH0_B_301	42%	75%	0.198	0.918	0.25	0.7	-	2	1	0	100%	1
8PRX_KH0_C_301	37%	79%	0.194	0.891	0.34	0.51	-	-	1	0	100%	1
8PRX_KH0_A_301	28%	82%	0.228	0.884	0.27	0.53	-	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.